Optics Technology Holding (300489.SZ) appoints Zhu Shibin as general manager
Guangzhi Technology (300489.SZ) announced that the company recently received the written resignation of its director and general manager, Mr. Liu Liuxian.
Optics Technology Holding (300489.SZ) announced that it has recently received a written resignation report from its director and general manager, Mr. Liu Liuyan. Due to work adjustment reasons, Mr. Liu Liuyan has applied to resign from his positions as director and general manager of the company, as well as resigning from the Strategic Committee of the fifth board of directors and all positions held in subsidiary companies. Mr. Liu Liuyan will not hold any other positions in the company or its subsidiaries after his resignation.
On December 26, 2024, the company held the 21st meeting of the fifth board of directors, and approved the resolution on appointing Mr. Zhu Shibin as the company's general manager. Nominated by the chairman of the board of directors and passed the qualification review of the nomination committee, the board of directors agreed to appoint Mr. Zhu Shibin as the company's general manager, relieving him of his position as deputy general manager, with a term from the date of the approval of this board meeting until the end of the term of the fifth board of directors.
Related Articles

CLOUDBREAK-B (02592) awarded 4.2842 million restricted stock units.

Huatai (06886): The face interest rate for the public offering of subordinated bonds (third tranche) for professional investors in 2025 is 2.24%.

US Stock Market Move | HSAI.US rose by 3%, receiving an increase in institutional forecasts for next year's revenue and net profit.
CLOUDBREAK-B (02592) awarded 4.2842 million restricted stock units.

Huatai (06886): The face interest rate for the public offering of subordinated bonds (third tranche) for professional investors in 2025 is 2.24%.

US Stock Market Move | HSAI.US rose by 3%, receiving an increase in institutional forecasts for next year's revenue and net profit.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025